The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Grants

EDCTP opened new calls for research proposals under its second programme: diagnostic tools for poverty-related diseases; maximising the impact of EDCTP research; strategic projects with major cofunding; improved treatment; and clinical management of poverty-related diseases.

Read more

About us

EDCTP is a partnership between Europa and sub-Saharan Africa, a partnership between 13 African and 13 European countries that jointly contribute to the fight against HIV/Aids, tuberculosis, malaria and other neglected infectious diseases.

Find out more about who we are!

Read more

Scope

EDCTP2 aims to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for PRDs in partnership with sub-Saharan Africa.

Read more

Latest news

26 February 2015

PanACEA MAMS-TB-01 trial: ‘high-dose rifampicin may help shorten TB treatment’

Published 26 February 2015

Read more
28 January 2015

Calls for Proposals: ‘Strategic projects with major cofunding’ and ‘Improved treatment and clinical management of poverty-related diseases’

Today, EDCTP published two new calls for proposals under its second programme. The call Strategic projects with major cofunding aims…

Read more